These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31594977)

  • 1. Hemophilia A and B mice, but not VWF
    Taves S; Sun J; Livingston EW; Chen X; Amiaud J; Brion R; Hannah WB; Bateman TA; Heymann D; Monahan PE
    Sci Rep; 2019 Oct; 9(1):14428. PubMed ID: 31594977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased bone resorption in hemophilia.
    Rodriguez-Merchan EC; Valentino LA
    Blood Rev; 2019 Jan; 33():6-10. PubMed ID: 29857920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.
    Baud'huin M; Duplomb L; Téletchéa S; Charrier C; Maillasson M; Fouassier M; Heymann D
    J Biol Chem; 2009 Nov; 284(46):31704-13. PubMed ID: 19758994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies.
    Shi Q; Schroeder JA; Kuether EL; Montgomery RR
    J Thromb Haemost; 2015 Jul; 13(7):1301-9. PubMed ID: 25955153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
    Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
    Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption.
    Recht M; Liel MS; Turner RT; Klein RF; Taylor JA
    Haemophilia; 2013 Nov; 19(6):908-12. PubMed ID: 23731369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy for Hemophilia.
    Nienhuis AW; Nathwani AC; Davidoff AM
    Mol Ther; 2017 May; 25(5):1163-1167. PubMed ID: 28411016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
    Milanov P; Ivanciu L; Abriss D; Quade-Lyssy P; Miesbach W; Alesci S; Tonn T; Grez M; Seifried E; Schüttrumpf J
    Blood; 2012 Jan; 119(2):602-11. PubMed ID: 22031860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIVV001, a new class of factor VIII replacement for hemophilia A that is independent of von Willebrand factor in primates and mice.
    Seth Chhabra E; Liu T; Kulman J; Patarroyo-White S; Yang B; Lu Q; Drager D; Moore N; Liu J; Holthaus AM; Sommer JM; Ismail A; Rabinovich D; Liu Z; van der Flier A; Goodman A; Furcht C; Tie M; Carlage T; Mauldin R; Dobrowsky TM; Liu Z; Mercury O; Zhu L; Mei B; Schellenberger V; Jiang H; Pierce GF; Salas J; Peters R
    Blood; 2020 Apr; 135(17):1484-1496. PubMed ID: 32078672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients.
    Swystun LL; Ogiwara K; Rawley O; Brown C; Georgescu I; Hopman W; Labarque V; Male C; Thom K; Blanchette VS; Carcao MD; Lillicrap D
    Blood; 2019 Sep; 134(11):880-891. PubMed ID: 31350267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes.
    Bastida JM; González-Porras JR; Jiménez C; Benito R; Ordoñez GR; Álvarez-Román MT; Fontecha ME; Janusz K; Castillo D; Fisac RM; García-Frade LJ; Aguilar C; Martínez MP; Bermejo N; Herrero S; Balanzategui A; Martin-Antorán JM; Ramos R; Cebeiro MJ; Pardal E; Aguilera C; Pérez-Gutierrez B; Prieto M; Riesco S; Mendoza MC; Benito A; Hortal Benito-Sendin A; Jiménez-Yuste V; Hernández-Rivas JM; García-Sanz R; González-Díaz M; Sarasquete ME
    Thromb Haemost; 2017 Jan; 117(1):66-74. PubMed ID: 27734074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia Gene Therapy: Ready for Prime Time?
    VandenDriessche T; Chuah MK
    Hum Gene Ther; 2017 Nov; 28(11):1013-1023. PubMed ID: 28793786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and treatment of osteoporosis in patients with hemophilia.
    Lin X; Gao P; Zhang Q; Jiang Y; Wang O; Xia W; Li M
    Arch Osteoporos; 2023 Jan; 18(1):17. PubMed ID: 36598583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet and endothelial expression of clotting factors for the treatment of hemophilia.
    Montgomery RR; Shi Q
    Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S46-8. PubMed ID: 22421106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis.
    Sun J; Hua B; Livingston EW; Taves S; Johansen PB; Hoffman M; Ezban M; Monroe DM; Bateman TA; Monahan PE
    Blood; 2017 Apr; 129(15):2161-2171. PubMed ID: 28039188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Therapy in Hemophilia: Recent Advances.
    Rodríguez-Merchán EC; De Pablo-Moreno JA; Liras A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII-deficient mice.
    Cooke EJ; Wyseure T; Zhou JY; Gopal S; Nasamran CA; Fisch KM; Manon-Jensen T; Karsdal MA; Mosnier LO; von Drygalski A
    J Thromb Haemost; 2019 Nov; 17(11):1815-1826. PubMed ID: 31301687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining severity of hemophilia: more than factor levels.
    Pavlova A; Oldenburg J
    Semin Thromb Hemost; 2013 Oct; 39(7):702-10. PubMed ID: 24026911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native-like aggregates of factor VIII are immunogenic in von Willebrand factor deficient and hemophilia a mice.
    Pisal DS; Kosloski MP; Middaugh CR; Bankert RB; Balu-Iyer SV
    J Pharm Sci; 2012 Jun; 101(6):2055-65. PubMed ID: 22388918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.